Hospira GemStar Infusion System Recalled by FDA for Battery Malfunction

An FDA Class 1 recall has been issued for Hospira’s GemStar Infusion System, a device for use in intravenous, arterial, subcutaneous, short-term infusion and parenteral administration of general IV fluids and medications, according to the American Society of Anesthesiologists.

Advertisement

The problem stems from the lithium battery voltage, which can drop below 2.4 volts and interrupt the device’s operations. The battery malfunction can also erase infusion settings and event history logs.

All lithium batteries older than three years should be replaced, according to the release. For more information, check with the FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

More Articles on Anesthesia:
Georgia-based Gwinnett Anesthesia Service Acquired by MEDNAX
Study: Neuraxial Anesthesia Brings Better Outcomes for Knee, Hip Arthroplasty
ASA Seeks Further Hardship Exemptions for Anesthesiologists

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.